
David W. Berke-schlessel
Examiner (ID: 6754, Phone: (571)270-3643 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1651, 1799 |
| Total Applications | 867 |
| Issued Applications | 517 |
| Pending Applications | 104 |
| Abandoned Applications | 260 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13314851
[patent_doc_number] => 20180208962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => MEDICINAL OROBANCHEACE EXTRACTS
[patent_app_type] => utility
[patent_app_number] => 15/933477
[patent_app_country] => US
[patent_app_date] => 2018-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15933477
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/933477 | Medicinal orobancheace extracts | Mar 22, 2018 | Issued |
Array
(
[id] => 13311345
[patent_doc_number] => 20180207209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => BIFIDOBACTERIA FOR TREATING CARDIAC CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 15/927986
[patent_app_country] => US
[patent_app_date] => 2018-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15927986
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/927986 | BIFIDOBACTERIA FOR TREATING CARDIAC CONDITIONS | Mar 20, 2018 | Abandoned |
Array
(
[id] => 13329203
[patent_doc_number] => 20180216139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => METHODS FOR ENHANCING BY PRODUCTS FROM FERMENTATION PROCESSES
[patent_app_type] => utility
[patent_app_number] => 15/926667
[patent_app_country] => US
[patent_app_date] => 2018-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15926667
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/926667 | METHODS FOR ENHANCING BY PRODUCTS FROM FERMENTATION PROCESSES | Mar 19, 2018 | Abandoned |
Array
(
[id] => 15646769
[patent_doc_number] => 20200085914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => COMPOSITIONS AND METHODS FOR WOUND HEALING
[patent_app_type] => utility
[patent_app_number] => 16/493896
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5248
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493896
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493896 | Compositions and methods for wound healing | Mar 15, 2018 | Issued |
Array
(
[id] => 15590283
[patent_doc_number] => 20200071676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => THREE-DIMENSIONAL CULTURE OF PRIMARY CANCER CELLS USING TUMOR TISSUE
[patent_app_type] => utility
[patent_app_number] => 16/494273
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494273
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494273 | Three-dimensional culture of primary cancer cells using tumor tissue | Mar 14, 2018 | Issued |
Array
(
[id] => 14003803
[patent_doc_number] => 10220332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Columns for isolation, detection and use of biological cells
[patent_app_type] => utility
[patent_app_number] => 15/901674
[patent_app_country] => US
[patent_app_date] => 2018-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 48370
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15901674
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/901674 | Columns for isolation, detection and use of biological cells | Feb 20, 2018 | Issued |
Array
(
[id] => 15751289
[patent_doc_number] => 10617727
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-14
[patent_title] => Treatment for gastroesophageal reflux disease caused by a neurological disorder
[patent_app_type] => utility
[patent_app_number] => 15/897597
[patent_app_country] => US
[patent_app_date] => 2018-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5616
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15897597
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/897597 | Treatment for gastroesophageal reflux disease caused by a neurological disorder | Feb 14, 2018 | Issued |
Array
(
[id] => 15469037
[patent_doc_number] => 10550383
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Galvanotaxis assay for quantitative assessment of the metastatic potential of cancer cells
[patent_app_type] => utility
[patent_app_number] => 15/887090
[patent_app_country] => US
[patent_app_date] => 2018-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 40
[patent_no_of_words] => 13628
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15887090
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/887090 | Galvanotaxis assay for quantitative assessment of the metastatic potential of cancer cells | Feb 1, 2018 | Issued |
Array
(
[id] => 12746407
[patent_doc_number] => 20180140636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => EXTRACELLULAR MATRIX FROM PLURIPOTENT CELLS
[patent_app_type] => utility
[patent_app_number] => 15/870701
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870701
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870701 | Extracellular matrix from pluripotent cells | Jan 11, 2018 | Issued |
Array
(
[id] => 12881125
[patent_doc_number] => 20180185550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => Microporous Hydrogel Scaffolds for Cell Transplantation
[patent_app_type] => utility
[patent_app_number] => 15/863843
[patent_app_country] => US
[patent_app_date] => 2018-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15863843
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/863843 | Microporous hydrogel scaffolds for cell transplantation | Jan 4, 2018 | Issued |
Array
(
[id] => 13309887
[patent_doc_number] => 20180206480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => PROTECTION OF PROGENITOR CELLS AND REGULATION OF THEIR DIFFERENTIATION
[patent_app_type] => utility
[patent_app_number] => 15/861182
[patent_app_country] => US
[patent_app_date] => 2018-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15861182
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/861182 | Protection of progenitor cells and regulation of their differentiation | Jan 2, 2018 | Issued |
Array
(
[id] => 12880366
[patent_doc_number] => 20180185297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => Serum Specific Drug Transport System
[patent_app_type] => utility
[patent_app_number] => 15/860555
[patent_app_country] => US
[patent_app_date] => 2018-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15860555
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/860555 | Serum Specific Drug Transport System | Jan 1, 2018 | Abandoned |
Array
(
[id] => 15420605
[patent_doc_number] => 10543204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Use of Hsp70 as a regulator of enzymatic activity
[patent_app_type] => utility
[patent_app_number] => 15/854352
[patent_app_country] => US
[patent_app_date] => 2017-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 47871
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15854352
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/854352 | Use of Hsp70 as a regulator of enzymatic activity | Dec 25, 2017 | Issued |
Array
(
[id] => 15342661
[patent_doc_number] => 20200009222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => THERAPEUTICALLY ACTIVE COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 16/468605
[patent_app_country] => US
[patent_app_date] => 2017-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16468605
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/468605 | THERAPEUTICALLY ACTIVE COMPLEXES | Dec 18, 2017 | Abandoned |
Array
(
[id] => 17266405
[patent_doc_number] => 11191809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Composition in powder form comprising iron-milk protein complexes and probiotic bacteria
[patent_app_type] => utility
[patent_app_number] => 16/462391
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9254
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462391
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462391 | Composition in powder form comprising iron-milk protein complexes and probiotic bacteria | Dec 13, 2017 | Issued |
Array
(
[id] => 12724606
[patent_doc_number] => 20180133369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => INJECTABLE COMPOSITION FOR IN-SITU REPAIR AND REGENERATION OF AN INJURED LIGAMENT OR TENDON AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/837300
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837300
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/837300 | Injectable composition for in-situ repair and regeneration of an injured ligament or tendon and methods of use | Dec 10, 2017 | Issued |
Array
(
[id] => 15541201
[patent_doc_number] => 10570366
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => Lactic acid bacterium having IgA production promoting activity, and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/835126
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8186
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15835126
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/835126 | Lactic acid bacterium having IgA production promoting activity, and use thereof | Dec 6, 2017 | Issued |
Array
(
[id] => 17322722
[patent_doc_number] => 11213709
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-04
[patent_title] => Bacterial strains and consortium comprising same for degrading MTBE, TBA and/or HCHO
[patent_app_type] => utility
[patent_app_number] => 16/464962
[patent_app_country] => US
[patent_app_date] => 2017-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 12
[patent_no_of_words] => 12761
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464962
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464962 | Bacterial strains and consortium comprising same for degrading MTBE, TBA and/or HCHO | Nov 28, 2017 | Issued |
Array
(
[id] => 17512089
[patent_doc_number] => 11291200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Application of viable cell monitor to cryopreservation of plant cells
[patent_app_type] => utility
[patent_app_number] => 16/347429
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4312
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347429
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347429 | Application of viable cell monitor to cryopreservation of plant cells | Nov 21, 2017 | Issued |
Array
(
[id] => 18700070
[patent_doc_number] => 11786556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Method for preparing a growth factors containing platelet releasate
[patent_app_type] => utility
[patent_app_number] => 16/462452
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7087
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 261
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462452
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462452 | Method for preparing a growth factors containing platelet releasate | Nov 19, 2017 | Issued |